Clinical Trial Update: DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial (DAHANCA 28A) investigates accelerated, hyperfractionated radiotherapy with concomitant cisplatin and nimorazole in head and neck cancers; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Laryngeal Cancer
• Oral Cavity Cancer
• Pharyngeal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Nimorazole (nimorazole)

Snippet

Sponsor: Danish Head and Neck Cancer Group | Conditions: HNSCC,Larynx, Pharynx and Oral Cavity | Phase 1, Phase 2 | Status: COMPLETED